H2AX and differentiated thyroid carcinoma: Recent studies by Scherthan and Lassmann [36, 37] measured the induction, persistence, and disappearance of radiation-induced γ-H2AX and 53BP1 foci after the first 131I therapy of patients with differentiated thyroid carcinoma.